BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND SOCS1, O15524, 8651, ENSG00000185338, SOCS-1, SSI-1, SSI1, Cish1, JAB, CISH1, CIS1, TIP3 AND Prognosis
5 results:

  • 1. Development of a novel six DNA damage response-related prognostic signature in osteosarcoma.
    Li T; Tang Z; Li S; Lu M
    Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):110-115. PubMed ID: 38650147
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification of signature genes and drug candidates for primary plasma cell leukemia: An integrated system biology approach.
    Chaudhary RK; Patil P; Ananthesh L; Gowdru Srinivasa M; Mateti UV; Shetty V; Khanal P
    Comput Biol Med; 2023 Aug; 162():107090. PubMed ID: 37295388
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Identification of ATG7 as a Regulator of Proferroptosis and Oxidative Stress in Osteosarcoma.
    Jiang R; He S; Gong H; Wang Y; Wei W; Chen J; Hu J; Ye C; LiuHuang S; Jin S; Wei H; Xu W; Xiao J
    Oxid Med Cell Longev; 2022; 2022():8441676. PubMed ID: 36254233
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Outstanding prognostic value of novel ferroptosis-related genes in chemoresistance osteosarcoma patients.
    Zhao J; Zhao Y; Ma X; Feng H; Jia L
    Sci Rep; 2022 Mar; 12(1):5029. PubMed ID: 35322804
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Inhibitory role of Gas6 in intestinal tumorigenesis.
    Akitake-Kawano R; Seno H; Nakatsuji M; Kimura Y; Nakanishi Y; Yoshioka T; Kanda K; Kawada M; Kawada K; Sakai Y; Chiba T
    Carcinogenesis; 2013 Jul; 34(7):1567-74. PubMed ID: 23430954
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.